The Quiet Hero & World Hepatitis Day

Posted by Jesse Gehris on Jul 28, 2019 8:00:00 AM

The largest internal organ in the human body is the liver. The liver aids in digestion, energy storage, removal of toxins from the body, and supports many other functions. Because of the important job requirements set forth for this internal organ, evolution has assured us complete regeneration, so long as 25% of the tissue remaining is healthy.

Read More

Tags: Central Laboratory, Clinical Trial, Drug Development, Bioanalytical Testing, Development, BioPharma, Liver, Hepatitis

Join Eurofins at the 2019 DIA Annual Meeting in San Diego, CA

Posted by Jesse Gehris on Jun 3, 2019 9:15:00 AM

Eurofins BioPharma Services will be attending the DIA Global Annual Meeting in San Diego, CA, June 23-27! Join us at Booth 1705 to discover how our dedicated BioPharma laboratories provide seamless, end-to-end solutions to help customers progress through the drug development cycle through a single, experienced provider!

Read More

Tags: Central Laboratory, Quality, Clinical Trial, Drug Development, Development, BioPharma, Gene Therapy

Eurofins Achieves 2019 CRO Leadership Award

Posted by Jesse Gehris on May 30, 2019 9:00:00 AM

For the 2019 CRO Leadership Awards, Life Science Leader magazine once again teamed up with Industry Standard Research (ISR) to determine the award recipients. More than 60 contract research organizations were assessed on over 20 performance metrics in ISR's annual CRO Quality Benchmarking survey. Eurofins is recognized as a recipient of these awards, exceeding customer expectations in every category.

Read More

Tags: Central Laboratory, Quality, Results, Drug Development, Development, BioPharma

FDA Efforts in Advancing Development of Gene Therapy

Posted by Brian Wile on May 24, 2019 9:25:52 AM

With Dr. Marks’ (Director, Center for Biologics Evaluation and Research), recent perspective on FDA’s Effort to Advance the Development of Gene Therapy, he thoughtfully highlights the recent successes of approved gene therapies, highlights the expert resourcing within FDA, CBER and NIH being applied towards this therapeutic specialization and details the innovative programs and committees (Novel and Exceptional Technology and Research Advisory Committee (NExTRAC), Regenerative Medicine Advanced Therapy (RMAT) designation and the INTERACT program) being instituted and enacted by the FDA.  In addition, he highlights the critical issue facing success of this scientific endeavor, is quality manufacturing capacity but attentively details FDA action of awarding grants dedicated to industry stakeholders for the advancement of manufacturing technologies.

Read More

Tags: FDA, Results, Drug Development, Cellular Response, Development, DNA, Gene Therapy

Eurofins Celebrates International Women's Day

Posted by Jesse Gehris on Mar 8, 2019 10:30:11 AM

Today, on March 8th, 2019, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, celebrates International Women's Day (IWD).

Read More

Tags: Central Laboratory, Quality, Results, Peace, Development, BioPharma, Leadership, International Women's Day

Newly Expanded Shanghai Facility

Posted by Jesse Gehris on Feb 26, 2019 11:52:02 AM

In 2017, China became the world's second-largest national pharmaceutical market, due to its aging population and rising medical needs. In its ongoing commitment to adapt to emerging trends in the pharmaceutical industry, Eurofins Central Laboratory,  a member of Eurofins BioPharma Services, has expanded its facility in Shanghai, China.

Read More

Tags: Central Laboratory, Clinical Trial, Development, Science Education, Shanghai

Happy Chinese New Year 2019!

Posted by Sandra Hageman on Feb 5, 2019 11:09:26 AM

新年快乐

Read More

Tags: Quality, Peace, Development, BioPharma, Chinese New Year, Year of the Pig

National Go Red Day

Posted by Jesse Gehris on Feb 1, 2019 12:30:00 PM

Today, at all four of our wholly-owned central laboratory testing facilities (United States, Netherlands, China, and Singapore), we at Eurofins Central Laboratory, a division of Eurofins BioPharma Services, wear red with the American Heart Association to aide in uniting the world from continent to continent in effort of bringing awareness to our friends, families, and colleagues suffering from cardiovascular-related diseases (CVD). Diseases under this remit include, but are not limited to, defects at birth, heart rhythm complications, and abnormal blood vessel conditions.

Read More

Tags: Quality, Results, Development, American Heart Month, Heart Disease, Healthy Lifestyle

Moebius Syndrome Awareness Day

Posted by Jesse Gehris on Jan 24, 2019 9:00:00 AM

Today we at Eurofins Central Laboratory recognize a rare neurological disorder known as Moebius Syndrome.

Read More

Tags: Central Laboratory, Clinical Trial, Bioanalytical Testing, Development, Science Education, BioPharma, Moebius Syndrome

Cervical Health Awareness Month

Posted by Jesse Gehris on Jan 3, 2019 2:00:00 PM

Throughout the month, Eurofins Central Laboratory, a member of Eurofins BioPharma Services, stands with the American Cancer Society to recognize January as Cervical Cancer Awareness Month. According to the World Health Organization (WHO):

Read More

Tags: Central Laboratory, Clinical Trial, Bioanalytical Testing, Development, Cervical Cancer